Yissum Research Development

Type

Other

Status

Active

Location

Jerusalem, Israel

Total investments

6

Average round size

5M

Portfolio companies

3

Rounds per year

0.11

Lead investments

1

Follow on index

0.50

Exits

1

Stages of investment
Private EquityEarly Stage Venture
Areas of investment
BiotechnologyGovernmentHealth CareEducationPharmaceuticalTherapeuticsBiopharmaAgriculture

Summary

In 1964 was created Yissum Technology Transfer Company of the Hebrew University, which is appeared as Corporate Investor. The main department of described Corporate Investor is located in the Jerusalem. The fund was located in Asia if to be more exact in Israel.

Among the most popular fund investment industries, there are Pharmaceutical, Agriculture. For fund there is a match between the location of its establishment and the land of its numerous investments - Israel. Among the most popular portfolio startups of the fund, we may highlight Agrinnovate India, Avraham Pharmaceuticals, Avraham Pharmaceuticals. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. The fund has exact preference in a number of founders of portfolio startups.

The increased amount of exits for fund were in 2015. Considering the real fund results, this Corporate Investor is 3 percentage points less often commits exit comparing to other organizations. The fund is constantly included in less than 2 investment rounds annually. This Yissum Technology Transfer Company of the Hebrew University works on 12 percentage points less the average amount of lead investments comparing to the other organizations. Deals in the range of 5 - 10 millions dollars are the general things for fund. The top activity for fund was in 2013.

The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the Yissum Technology Transfer Company of the Hebrew University, startups are often financed by Clal Biotechnology Industries, Technion Research & Development Foundation, Pontifax. The meaningful sponsors for the fund in investment in the same round are Clal Biotechnology Industries, Technion Research & Development Foundation, Pontifax. In the next rounds fund is usually obtained by Clal Biotechnology Industries, Technion Research & Development Foundation, Integra LifeSciences.

Show more

Investor highlights

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
6
Lead investments
1
Exits
1
Rounds per year
0.11
Follow on index
0.50
Investments by industry
  • Biotechnology (5)
  • Pharmaceutical (4)
  • Health Care (4)
  • Therapeutics (1)
  • Biopharma (1)
  • Show 3 more
Investments by region
  • Israel (4)
  • United States (1)
  • India (1)
Peak activity year
2011

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
14
Group Appearance index
1.00
Avg. company exit year
20

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Agrinnovate India 26 Oct 2015 Government, Education, Agriculture Early Stage Venture 4M India, Delhi, New Delhi

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.